Detalles de la búsqueda
1.
Radium-223 in women with hormone receptor-positive bone-metastatic breast cancer receiving endocrine therapy: pooled analysis of two international, phase 2, randomized, double-blind, placebo-controlled trials.
Breast Cancer Res Treat
; 204(2): 249-259, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38123789
2.
Aging-accumulated methylmalonic acid serum levels at breast cancer diagnosis are not associated with distant metastases.
Breast Cancer Res Treat
; 2024 Mar 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-38472594
3.
Abemaciclib plus endocrine therapy for hormone receptor-positive, HER2-negative, node-positive, high-risk early breast cancer (monarchE): results from a preplanned interim analysis of a randomised, open-label, phase 3 trial.
Lancet Oncol
; 24(1): 77-90, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36493792
4.
Circulating biomarkers at diagnosis correlate with distant metastases of early luminal-like breast cancer.
Genes Immun
; 24(5): 270-279, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37759086
5.
AMEERA-4: a randomized, preoperative window-of-opportunity study of amcenestrant versus letrozole in early breast cancer.
Breast Cancer Res
; 25(1): 141, 2023 11 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37950338
6.
XENERA-1: a randomised double-blind Phase II trial of xentuzumab in combination with everolimus and exemestane versus everolimus and exemestane in patients with hormone receptor-positive/HER2-negative metastatic breast cancer and non-visceral disease.
Breast Cancer Res
; 25(1): 67, 2023 06 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37308971
7.
Overall Survival with Ribociclib plus Fulvestrant in Advanced Breast Cancer.
N Engl J Med
; 382(6): 514-524, 2020 02 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31826360
8.
Pan-Cancer Detection and Typing by Mining Patterns in Large Genome-Wide Cell-Free DNA Sequencing Datasets.
Clin Chem
; 68(9): 1164-1176, 2022 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35769009
9.
Randomized CLIO/BGOG-ov10 trial of olaparib monotherapy versus physician's choice chemotherapy in relapsed ovarian cancer.
Gynecol Oncol
; 165(1): 14-22, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35177277
10.
ROSALINE: a phase II, neoadjuvant study targeting ROS1 in combination with endocrine therapy in invasive lobular carcinoma of the breast.
Future Oncol
; 18(22): 2383-2392, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-35695563
11.
Alpelisib plus fulvestrant in PIK3CA-mutated, hormone receptor-positive advanced breast cancer after a CDK4/6 inhibitor (BYLieve): one cohort of a phase 2, multicentre, open-label, non-comparative study.
Lancet Oncol
; 22(4): 489-498, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33794206
12.
Abemaciclib plus fulvestrant in hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer in premenopausal women: subgroup analysis from the MONARCH 2 trial.
Breast Cancer Res
; 23(1): 87, 2021 08 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-34425869
13.
A phase Ib/II study of xentuzumab, an IGF-neutralising antibody, combined with exemestane and everolimus in hormone receptor-positive, HER2-negative locally advanced/metastatic breast cancer.
Breast Cancer Res
; 23(1): 8, 2021 01 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33451345
14.
Clinical behavior of recurrent hormone receptor-positive breast cancer by adjuvant endocrine therapy within the Breast International Group 1-98 clinical trial.
Cancer
; 127(5): 700-708, 2021 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33290610
15.
Safety and impact of dose reductions on efficacy in the randomised MONALEESA-2, -3 and -7 trials in hormone receptor-positive, HER2-negative advanced breast cancer.
Br J Cancer
; 125(5): 679-686, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34158598
16.
The efficacy and safety of enzalutamide with trastuzumab in patients with HER2+ and androgen receptor-positive metastatic or locally advanced breast cancer.
Breast Cancer Res Treat
; 187(1): 155-165, 2021 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33591468
17.
Cumulative incidence of cardiovascular events under tamoxifen and letrozole alone and in sequence: a report from the BIG 1-98 trial.
Breast Cancer Res Treat
; 185(3): 697-707, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-33159633
18.
Concordance between results of inexpensive statistical models and multigene signatures in patients with ER+/HER2- early breast cancer.
Mod Pathol
; 34(7): 1297-1309, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33558657
19.
Radical hysterectomy without adjuvant radiotherapy in patients with cervix carcinoma FIGO 2009 IB1, with or without positive Sedlis criteria.
Gynecol Oncol
; 162(3): 539-545, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34253389
20.
Postpartum breast cancer: mechanisms underlying its worse prognosis, treatment implications, and fertility preservation.
Int J Gynecol Cancer
; 31(3): 412-422, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33649008